Company Filing History:
Years Active: 2010
Title: Colin Patrick McGuckin: Innovator in Gene Regulation
Introduction
Colin Patrick McGuckin is a notable inventor based in Surrey, GB. He has made significant contributions to the field of gene regulation through his innovative research and patents. His work focuses on the development of peptides that can impair PBX-dependent gene transcription, which has potential implications in various biological processes.
Latest Patents
Colin holds a patent for "Peptides impairing PBX dependent gene regulation." This invention relates to peptides that interfere with PBX-dependent regulation of gene transcription. Specifically, the patent describes the use of a peptide comprising the amino acid sequence XXXW M XXXX, where the sequence X to X is an amino acid sequence of at least 9 amino acids, which may be interrupted by one or two amino acid residues between some of the defined positions. This innovative approach could lead to advancements in genetic research and therapeutic applications.
Career Highlights
Colin Patrick McGuckin is affiliated with St George's Hospital Medical School, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to influence the understanding of gene regulation mechanisms. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the scientific community.
Collaborations
Colin has collaborated with esteemed colleagues such as Richard George Leonard Morgan and Ruth Pettengell. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field of gene regulation.
Conclusion
Colin Patrick McGuckin is a distinguished inventor whose work in gene regulation through peptide development showcases his innovative spirit. His contributions to the field are significant and continue to inspire further research and exploration.